You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Purpura fulminans

Showing 1 - 25 of 225
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies

Completed
  • Idiopathic Purpura
    • Montpellier, France
      Uhmontpellier
    Oct 22, 2021

    Long-term Sequelae of Childhood Meningitis and Meningococcal

    Recruiting
    • Meningitis, Meningococcal
    • Sequela
    • sequela evaluation
    • Argenteuil, France
    • +7 more
    Aug 2, 2021

    Sepsis Trial in Jena, Munich

    Completed
    • Sepsis
      • Jena, Germany
      • +2 more
      Feb 18, 2021

      Congenital Protein C Deficiency Trial in Kashihara, Chiba, Saitama (TAK-662)

      Active, not recruiting
      • Congenital Protein C Deficiency
      • Kashihara, Nara, Japan
      • +3 more
      Apr 7, 2022

      Protein C Deficiency Trial in United States (Protein C Concentrate (Human) Vapor Heated)

      Completed
      • Protein C Deficiency
      • Protein C Concentrate (Human) Vapor Heated
      • Los Angeles, California
      • +11 more
      May 3, 2021

      Data in Severe Congenital Protein C Deficiency Who Were Treated

      Completed
      • Protein C Deficiency
      • Protein C Concentrate (Human) Vapor Heated
      • Los Angeles, California
      • +9 more
      Apr 7, 2021

      Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi

      Completed
      • Cutaneous Manifestations
      • +7 more
        • Karachi, Sindh, Pakistan
          Jinnah Postgraduate Medical Centre
        Nov 12, 2021

        Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

        Not yet recruiting
        • ITP - Immune Thrombocytopenia
        • eltrombopag and romiplastim
        • (no location specified)
        Nov 16, 2023

        Outcomes of Purpura FULminans in Adults - The hOPeFUL Study

        Completed
        • Purpura Fulminans
        • Phone interview measuring health-related quality of life variables
        • Aulnay-sous-Bois, France
        • +25 more
        Mar 8, 2018

        Henoch-Schonlein Purpura Trial in Guangzhou (Leflunomide)

        Recruiting
        • Henoch-Schonlein Purpura
        • Guangzhou, Guangdong, China
          Sun Yat-sen Memorial Hospital, Sun Yat-sen University
        Jul 1, 2023

        Rheumatoid Purpura in Children:Multicenter Observational Study

        Not yet recruiting
        • Rheumatoid Purpura
        • Management of rheumatoid purpura
        • (no location specified)
        Feb 10, 2023

        COVID-19 Vaccine and Development of Immune Thrombocytopenic

        Recruiting
        • COVID-19 Vaccine
        • covid19 vaccines
        • Assiut, Egypt
          Egypt
        Jul 12, 2022

        Purpura, Schoenlein-Henoch Trial in Changchun (IL-2)

        Completed
        • Purpura, Schoenlein-Henoch
        • Changchun, Changchun/JiLin, China
          Sirui Yang
        Aug 16, 2022

        Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)

        Completed
        Has Results
        • Idiopathic Thrombocytopenic Purpura
        • Placebo
        • AMG 531
        • (no location specified)
        Nov 4, 2022

        Purpura, Thrombocytopenic Trial in Sevilla (Standard clinical practice)

        Not yet recruiting
        • Purpura, Thrombocytopenic
        • Standard clinical practice
        • Sevilla, Andalucia, Spain
          Hospital Universitario Virgen del Rocío
        Jun 13, 2023

        Henoch-Schönlein Purpura, Gastrointestinal Injury, Mycophenolate Mofetil Trial in Guangzhou (MMF)

        Recruiting
        • Henoch-Schönlein Purpura
        • +2 more
        • Guangzhou, Guangdong, China
          Sun Yat-sen Memorial Hospital, Sun Yat-sen University
        Jul 18, 2023

        Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)

        Enrolling by invitation
        • Idiopathic Thrombocytopenic Purpura
        • GNR-069
        • Irkutsk, Irkutsk Region, Russian Federation
        • +12 more
        Aug 5, 2022

        Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069, Nplate)

        Recruiting
        • Idiopathic Thrombocytopenic Purpura
        • GNR-069
        • Nplate
        • Irkutsk, Irkutsk Region, Russian Federation
        • +17 more
        Aug 3, 2022

        Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

        No longer available
        • Thrombotic Thrombocytopenic Purpura (TTP)
        • (no location specified)
        Mar 3, 2023

        TTP - Thrombotic Thrombocytopenic Purpura Trial in Ankara

        Recruiting
        • TTP - Thrombotic Thrombocytopenic Purpura
          • Ankara, Turkey
            Baskent Universtiy Faculty of Medicine
          Jul 15, 2023

          TTP Patients: Italian Experience (ROSCAPLI)

          Recruiting
          • Thrombotic Thrombocytopenic Purpura
          • Roma, Italy
            FPG
          Mar 14, 2023

          Pediatric Primary Immune Thrombocytopenia (ITP)

          Recruiting
          • Primary Immune Thrombocytopenia
          • data collection
          • Tianjin, China
            Chinese Academy of Medical Science and Blood Disease Hospital
          Oct 31, 2023

          Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Standard of Care)

          Completed
          Has Results
          • Acquired Thrombotic Thrombocytopenic Purpura
          • Caplacizumab
          • Standard of Care
          • Saint Louis, Missouri
          • +44 more
          Mar 21, 2022

          .German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

          Recruiting
          • Thrombotic Thrombocytopenic Purpura
            • Mainz, Germany
              University Hospital Mainz, Hematology
            May 20, 2022

            Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)

            Active, not recruiting
            • Idiopathic Thrombocytopenic Purpura
            • Multiple Locations, Japan
              Research Site
            Mar 22, 2022